ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 25 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $22,000 | -89.6% | 10,064 | -88.3% | 0.00% | -100.0% |
| Q4 2020 | $212,000 | -37.6% | 85,654 | -25.4% | 0.01% | -58.3% |
| Q2 2020 | $340,000 | -16.9% | 114,829 | -25.8% | 0.01% | -45.5% |
| Q1 2020 | $409,000 | -47.6% | 154,658 | -1.5% | 0.02% | -38.9% |
| Q4 2019 | $780,000 | -7.1% | 156,944 | +11.3% | 0.04% | -21.7% |
| Q3 2019 | $840,000 | -6.0% | 141,012 | +1.8% | 0.05% | +4.5% |
| Q2 2019 | $894,000 | -8.5% | 138,541 | -4.2% | 0.04% | -15.4% |
| Q1 2019 | $977,000 | +64.5% | 144,583 | -0.9% | 0.05% | +23.8% |
| Q4 2018 | $594,000 | – | 145,844 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
| Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
| Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
| Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
| Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
| Granahan Investment Management | 141,012 | $840,000 | 0.05% |
| Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
| BlackRock Inc. | 15,755 | $94,000 | 0.00% |